Skip to main content

Mates Sharon's Form 4 filing

Intra-Cellular Therapies, Inc. (ITCI) · filed Jan 18, 2024

Accession no.
0000950170-24-005557
Filed
Jan 18, 2024
Trade date
Jan 16-18, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 10 non-derivative transactions and 3 derivative transactions. Open-market sales total $12.7M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mates SharonCIK 0001585699Director, Officer (Chairman, President & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 16, 2024Common StockMOption exerciseAcquired+75,361$16.86+$1,270,586.461,125,670Direct
Jan 16, 2024Common StockSSaleDisposed−3,500$66.38−$232,3301,122,170Direct
Jan 16, 2024Common StockSSaleDisposed−65,979$67.25−$4,437,087.751,056,191Direct
Jan 16, 2024Common StockSSaleDisposed−5,882$67.76−$398,564.321,050,309Direct
Jan 17, 2024Common StockMOption exerciseAcquired+48,084$16.86+$810,696.241,098,393Direct
Jan 17, 2024Common StockSSaleDisposed−30,633$66.00−$2,021,7781,067,760Direct
Jan 17, 2024Common StockSSaleDisposed−17,451$66.66−$1,163,283.661,050,309Direct
Jan 18, 2024Common StockMOption exerciseAcquired+67,917$16.86+$1,145,080.621,118,226Direct
Jan 18, 2024Common StockSSaleDisposed−67,597$65.19−$4,406,648.431,050,629Direct
Jan 18, 2024Common StockSSaleDisposed−320$66.25−$21,2001,050,309Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 16, 2024Common StockMOption exerciseDisposed−75,361$0.00$0124,639Direct
Jan 17, 2024Common StockMOption exerciseDisposed−48,084$0.00$076,555Direct
Jan 18, 2024Common StockMOption exerciseDisposed−67,917$0.00$08,638Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)